Le Pubblicazioni

Le principali pubblicazioni dei dottori della fondazione ARCO di Cuneo sono reperibili al sito http://www.ncbi.nlm.nih.gov/pubmed.

A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinoma.

Posted on 10 dicembre 2014

A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinoma.

Messa F, Tonissi F, Millo E, Bracco E, Ungari S, Lattanzio L, Merlano M, Damonte G, Lo Nigro C.

Int J Biol Markers. 2014 Mar 24;29(1):e55-61. doi: 10.5301/jbm.5000052.

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.

Posted on 10 dicembre 2014

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, Lattanzio L, Chmielewska-Kassassir M, Tomlinson I, Roylance R, Whitaker HC, Warren AY, Neal D, Frezza C, […]

How detection of epigenetic alterations of blood-borne DNA could improve melanoma diagnosis.

Posted on 10 dicembre 2014

How detection of epigenetic alterations of blood-borne DNA could improve melanoma diagnosis.

Hatzimichael E, Syed N, Lo Nigro C, Rao B, Crook T.

Expert Rev Mol Diagn. 2014 Jul;14(6):639-42. doi: 10.1586/14737159.2014.928204. Epub 2014 Jun 13.

Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer.

Posted on 10 dicembre 2014

Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer. Rudraraju B, Droog M, Abdel-Fatah TM, Zwart W, Giannoudis A, Malki MI, Moore D, Patel H, Shaw J, Ellis IO, Chan S, Brooke GN, Nevedomskaya E, Lo Nigro C, Carroll J, Coombes RC, Bevan […]